Moomoo AIのまとめ
On December 31, 2023, Intelligent Bio Solutions Inc. was the subject of a Schedule 13G filing with the SEC, indicating changes in ownership by several related entities and individuals. Bigger Capital Fund, LP, along with its general partner Bigger Capital Fund GP, LLC, and several associated entities including District 2 Capital Fund LP, District 2 Capital LP, District 2 GP LLC, District 2 Holdings LLC, and individual Michael Bigger, reported ownership of warrants to purchase shares of Intelligent Bio Solutions. The warrants held by each entity and Michael Bigger individually allow for the purchase of 75,758 shares, except for Michael Bigger who holds warrants for 151,516 shares. Collectively, these holdings represent less than one percent of the company's class of securities for each reporting entity, with Michael Bigger's stake amounting to approximately 1.7%. The filing, dated February 5, 2024, asserts that the securities were not acquired for the purpose of changing or influencing the control of Intelligent Bio Solutions Inc. and were not held in connection with any transaction having that purpose or effect.
On December 31, 2023, Intelligent Bio Solutions Inc. was the subject of a Schedule 13G filing with the SEC, indicating changes in ownership by several related entities and individuals. Bigger Capital Fund, LP, along with its general partner Bigger Capital Fund GP, LLC, and several associated entities including District 2 Capital Fund LP, District 2 Capital LP, District 2 GP LLC, District 2 Holdings LLC, and individual Michael Bigger, reported ownership of warrants to purchase shares of Intelligent Bio Solutions. The warrants held by each entity and Michael Bigger individually allow for the purchase of 75,758 shares, except for Michael Bigger who holds warrants for 151,516 shares. Collectively, these holdings represent less than one percent of the company's class of securities for each reporting entity, with Michael Bigger's stake amounting to approximately 1.7%. The filing, dated February 5, 2024, asserts that the securities were not acquired for the purpose of changing or influencing the control of Intelligent Bio Solutions Inc. and were not held in connection with any transaction having that purpose or effect.
2023年12月31日、インテリジェントバイオソリューションズ社は、関連する複数のエンティティおよび個人による所有権の変更を示すSECによるスケジュール13Gの提出対象となりました。Bigger Capital Fund、LP、Bigger Capital Fund GP、LLCを含む複数の関連するエンティティ、District 2 Capital Fund LP、District 2 Capital LP、District 2 GP LLC、District 2 Holdings LLC、および個人のMichael Biggerは、Intelligent Bio Solutionsの株式購入...すべて展開
2023年12月31日、インテリジェントバイオソリューションズ社は、関連する複数のエンティティおよび個人による所有権の変更を示すSECによるスケジュール13Gの提出対象となりました。Bigger Capital Fund、LP、Bigger Capital Fund GP、LLCを含む複数の関連するエンティティ、District 2 Capital Fund LP、District 2 Capital LP、District 2 GP LLC、District 2 Holdings LLC、および個人のMichael Biggerは、Intelligent Bio Solutionsの株式購入オプションに対する証券保有と報告しました。各エンティティおよび個人の保有するワラントは、75,758株の購入を許可していますが、Michael Biggerは151,516株のワラントを保有しています。集計すると、これらの保有は、それぞれの報告エンティティの会社の証券クラスの1％未満をさらにMichael Biggerの株式比率が約1.7％です。2024年2月5日付の提出によると、証券はIntelligent Bio Solutions Inc.のコントロールを変更または影響する目的で取得されたものではなく、その目的または効果を持つ取引と関連して保有されていませんでした。
役に立った
役に立たない